Introduction
Laparoscopic abdominal surgeries have become the main modality of surgery nowadays due to its minimally invasive nature and decreased duration of hospital stay. Patients come in for a day care surgery or get discharged the following day with expectation of a pain-free post-operative period as most of them expect to return to their day-to-day activities sooner than following open surgery. Although pain is less intense following laparoscopic surgery than after open surgery, some patients nevertheless experience significant discomfort in the first 24 hours after surgery.1, 2
This calls for an adequate pain management that keeps the patient comfortable and pain-free. Laparoscopic surgeries are conducted under general anaesthesia with either inhalational and intravenous drugs or a combination of both for induction and maintenance. Anaesthesiologists have used either intraoperative or post-operative opioid infusions or bolus doses for pain management. The problem arises when patients develop side effects such as nausea, vomiting, respiratory depression, dependence on administration of opioids for pain relief.
To avoid the adverse effects of opioid usage that further prolongs the hospital stay, an opioid-free multimodal approach for analgesia can be applied. Because smaller doses of synergistically interacting drugs can be administered, some adverse effects might be reduced.3 This decreases the opioid dosage used while simultaneously providing adequate pain relief. As the pain from laparoscopic surgery is multifactorial, several methods of analgesia combined will help reduce the postoperative pain. The concept of multimodal analgesia is to administer multiple drugs that act at different levels of the pain pathway thereby producing better analgesia than a single drug.
Intraoperatively, pain cannot be directly assessed when the patient is under general anaesthesia. However, the hemodynamic stability and depth of anaesthesia can be assessed by measuring the heart rate, blood pressure and BIS values thereby indirectly giving an idea of adequacy of analgesia and response to various stresses and stimuli during the surgery.
The most common opioid used for analgesia during anaesthesia is fentanyl. Replacing this opioid with multiple drugs like dexmedetomidine, lignocaine, dexamethasone, magnesium sulphate and ketamine seems to give adequate analgesia with minimal adverse effects. Additionally, the amount of analgesic needed in the post operative period has also been shown to be reduced.4, 5
There are increasing number of studies on opioid free anaesthesia and multi modal analgesia and the results are showing similar or better results than opioid based anaesthesia with regards to postoperative pain, analgesic requirement, duration of PACU stay and adverse effects.4, 6
Therefore, in our study we aim to compare the intraoperative hemodynamic stability and depth of anaesthesia in patients undergoing laparoscopic abdominal surgeries under opioid based vs opioid free anaesthesia using the following drugs: Dexmedetomidine, Lignocaine, Ketamine and Dexamethasone.
Aim and Objectives
Materials and Methods
After ethical committee approval and written informedconsent we conducted a prospective randomized comparative study with study population of patients admitted for laparoscopic abdominal surgeries lasting less than three hours sampling by block Randomization technique with sample size of 60 (30 in each group).
We included ASA Grade 1 – 2 patients, age within 18 – 70 years, posted for elective laparoscopic surgeries less than 3 hours such as laparoscopic cholecystectomy, laparoscopic appendicectomy. The exclusions were: Patient refusal, patients with known allergy to study drugs, patients with opioid addiction, patients with dysrhythmias, congestive heart failure, morbid obesity (BMI> 35), patients on opioids or non-steroidal anti-inflammatory drugs within 1 week, or for chronic pain treatment.
Methodology
All the patients were examined prior to study. Patients’ pre anaesthetic check-up including detailed history, general physical and systemic examination and all necessary investigations needed for the conduct of anaesthesia was done. Patients were kept nil oral from midnight before the day of surgery. In the operating theatre, pulse oximeter, non-invasive blood pressure and ECG monitors were attached and baseline values were recorded. IV access was secured with an IV cannula. BIS monitor was attached appropriately and baseline value noted. Preoxygenation was done for 3 minutes before induction of anaesthesia.
Opioid based group (Group A)
In the opioid-based group, anaesthesia was induced with Inj. Fentanyl 2 µg/kg and Inj. Propofol 2 mg/kg. Followed by Inj. Atracurium 0.5 mg/kg for tracheal intubation. A repeat dose of Inj. Fentanyl 1 µg/kg was given at 2 hours intraoperatively.
Opioid free group (Group B)
In the opioid-free group, following a loading dose of Inj. Dexmedetomidine 1 µg/kg over 10 min, anaesthesia was induced with Inj. Propofol 2 mg/kg. Followed by Inj. Atracurium 0.5 mg/kg and Inj. Dexmedetomidine infusion 0.5 µg/kg/hr. Inj. Lignocaine 1.5 mg/kg was administered at induction and an infusion of 1.5 mg/kg/hr was started immediately after the loading dose. Inj. Dexamethasone 8 mg was given intravenously at induction. Inj. Ketamine 0.5 mg/kg was given before incision in this group.
Both Groups
After intubation, patient’s lungs were mechanically ventilated with an oxygen-air mixture to maintain end-tidal CO2 between 35- and 40-mm Hg. The patients were maintained with 1.0 MAC (Minimum Alveolar Concentration) Sevoflurane. Depth of anesthesia was evaluated by monitoring intraoperative hemodynamic values (heart rate, blood pressure) and BIS value every 15 minutes. 4 mg of Inj. Ondansetron iv and Inj. Pantaprazole 40 mg iv was administered intraoperatively in both groups for prevention of postoperative nausea and vomiting. Paracetamol iv 1 gm was given in both groups before the end of surgery. At the end of surgery, neuromuscular blockade was reversed using intravenous Inj. Neostigmine (0.05 mg/kg) and Inj. Glycopyrrolate (0.01mg/kg). The trachea was extubated when adequate spontaneous ventilation (tidal volume> 4 ml/kg) was established. Both lignocaine and dexmedetomidine infusions were stopped before extubation.
Statistical analysis
Normality of the continuous variables was assessed by Shapiro-Wilk’s test. Normally distributed continuous variable was expressed as Mean ± SD, otherwise median (Interquartile range-IQR). Categorical variables was expressed as percentage. Comparison of continuous variables which are normally distributed, was done by sample t test, otherwise Mann-Whitney U test. Comparison of categorical variables was done by Chi2 test/ Fisher’s Exact test. Data entry was done using Microsoft excel spreadsheet. Data analysis was carried out by SPSS version 25.0. All p values <0.05 was considered as statistically significant.
Observation and Results
60 patients admitted for laparoscopic abdominal surgeries were randomized into 2 groups: Group A (n=30) with fentanyl and Group B(n=30) with dexmedetomidine, lignocaine, ketamine and dexamethasone. Clinical parameters were studied in both the groups.
Confounding variables such as age, sex and duration of surgery were all comparable in both the groups.
Age and weight distribution
Table 1
|
Group |
N |
Mean |
Std. Deviation |
P value |
Age |
Group A |
30 |
40.90 |
13.785 |
0.888 |
Group B |
30 |
40.43 |
11.702 |
||
Weight |
Group A |
30 |
64.97 |
12.249 |
0.485 |
Group B |
30 |
67.03 |
10.480 |
Our objective was to compare depth of anaesthesia, intraoperative heart rate and mean arterial pressures between the opioid-based group and opioid free groups. The parameters assessed were heart rate, mean arterial pressure and bispectral index.
Table 2
The heart rate at extubation was significantly lower in group B than group A (p<0.05). The heart rates at all other times showed no significant difference.
Systolic blood pressure (SBP)
The SBP showed significant difference(p<0.05) at 5 mins after intubation, 45 mins, 1 hour, 1 hour 15 mins, at extubation, 5 mins after extubation and at recovery room.
Table 3
Table 4
Discussion
In recent years, opioids have been widely used perioperatively for analgesic purposes. The intraoperative use of either large bolus doses or continuous infusions of opioids is linked with postoperative hyperalgesia7 and increased analgesic consumption. In day-care surgeries, opioid related side effects, such as postoperative nausea and vomiting (PONV), prolonged sedation, ileus and urinary retention may delay recovery and discharge or cause unanticipated hospital readmission. The postoperative pain after laparoscopic surgery is complex in nature and therefore its treatment should be multimodal and opioid sparing to accelerate recovery.8
Although a single anaesthetic drug, such as an inhaled agent or propofol, can produce unconsciousness and immobilisation, achieving autonomic nervous system (ANS) control during surgery with just one drug is far more difficult and requires much greater concentrations. Without frequent, severe pre-stimulus haemodynamic depression and prolonged recovery, hypnotic medications administered alone cannot prevent heart rate and blood pressure increases in response to surgical stimulation. To suppress ANS responses to nociception, anaesthetic practitioners have used two medications in recent decades: an inhaled agent or propofol in conjunction with a second drug. Opioids have been the most regularly employed second medication since the introduction of the balanced anaesthesia approach. Opioids have a long history of use in modulating ANS responses to nociception and have also played an important role in postoperative pain management.3
In the past few years, the idea of multimodal approach in general anaesthesia has grown to encompass more medicines that target diverse neuroanatomical circuits and multiple neurophysiologic mechanisms, replicating the multimodal analgesia model in the acute pain management area. Short acting opioids (e.g., remifentanil), alpha-2 agonists (e.g., dexmedetomidine), local anaesthetics (e.g., lignocaine), and N-methyl-D-aspartate receptor antagonists (e.g., magnesium, ketamine) are all included in the suggested pharmacopoeia for multimodal general anaesthesia. The pharmacologic foundation of multimodal general anaesthesia approach is based on the well-established finding that when anaesthetic medicines with diverse mechanisms are combined, they often interact synergistically, similar to balanced anaesthesia. This synergy affords certain advantages, including faster recovery because the slope of the concentration-effect relationship steepens with synergy, meaning that small reductions in drug concentration lead to larger decreases in drug effect, fastening the passive process of anaesthetic emergence. Because smaller doses of synergistically interacting drugs can be administered, some dose-related adverse effects can be prevented.3
Nowadays propofol is used as an induction agent and the second drug used commonly is an opioid. The most common opioid adjunct that is being used is fentanyl which is a synthetic opioid. Opioid has side effects like itching, nausea, vomiting, constipation, respiratory depression, drowsiness, reduced concentration and attention.3
In our study, we chose to study multimodal anaesthesia using the following drugs: Dexmedetomidine which is an α2 agonist, lignocaine which is a sodium channel blocker with analgesic property, ketamine which is an NMDA antagonist and dexamethasone, a corticosteroid with added analgesic potency, in comparison with the traditional method of employing a single opioid drug i.e., Fentanyl for analgesia.
Our prospective randomized double blinded study included 60 patients belonging to ASA physical status I and II posted for laparoscopic surgeries of duration less than 3 hours. The surgeries included are laparoscopic cholecystectomy and laparoscopic appendicectomy.
All the 60 patients were randomized into 2 groups with 30 in each group. Group A received 2 mcg/kg of fentanyl along with 2 mg/kg of Propofol and 0.5 mg/kg atracurium for muscle relaxation and group B received 1 mcg/kg of dexmedetomidine in 10 minutes as loading dose and lignocaine 1.5 mg/kg bolus dose along with 2 mg/kg of Propofol and 0.5 mg atracurium.
The doses of dexmedetomidine, lignocaine, fentanyl and atracurium used in our study was based on the study by Bakan M et al8 where they used 0.6 mcg/kg dexmedetomidine as bolus, 2 mcg/kg fentanyl, 1.5 mg/kg lignocaine and 0.5 mg/kg atracurium.
From the study by Bhardwaj et al9 and Gurbet A et al,4we based our infusion doses for dexmedetomidine and lignocaine.
Hemodynamic stability
In the studies done by Bhardwaj et al9 and Bushra Abdul Hadi et al,5 there were no significant changes in the perioperative hemodynamic profile. Bakan M et al8 in their study determined that heart rate and mean arterial pressure values after induction, at intubation and 1st, 4th, 7th and 10th min of pneumoperitoneum were significantly higher in the group using dexmedetomidine and lignocaine. N. Turgut et al10 in their study determined that though heart rates did not vary among the two groups MAP values in dexmedetomidine group were significantly higher than in Fentanyl group only after intubation while before and after extubation MAP values were higher in the fentanyl group. The previous studies comparing opioid free anaesthesia with opioid based anaesthesia have primarily focussed on the post-operative analgesia, total analgesic use, patient comfort and recovery.
In our study intraoperative hemodynamics is the primary objective. We recorded the heart rate, mean arterial blood pressures right from baseline, through extubation till the patient reaches recovery room. We found that in the heart rate, there was not much difference except during extubation where the heart rate was significantly lower in group B. At extubation the mean heart rate in Group A was 94.03 while in Group B it was 81.33.
Among the mean arterial pressures, in our study, there was significant difference after induction, 1 and 5 minutes after intubation, and at extubation. Similar to previous studies by Bakan M et al8 and N. Turgut et al,10 at the above-mentioned times, MAP was higher in group B i.e., in the opioid free group.
In the study by Bakan M et al,8 during anaesthesia, remifentanil group experienced more hypotensive episodes, while dexmedetomidine and lignocaine group experienced more hypertensive events, both of which were statistically significant. There were no such hypotensive or hypertensive occurrences in our study.
In view of the heart rate (HR) and mean arterial pressure (MAP) values in Group B, our results reflect that of previous observations. Though we found no significant reduction in HR in group B, there was significant increase in MAP when compared to group A. Our observations may be due to the biphasic response of the drug Dexmedetomidine - an initial increase in blood pressure and a decrease in heart rate as a reflex due to a2b receptor stimulation.11
Depth of anaesthesia
Bakan M et al8 and Bhardwaj et al9 had both monitored BIS in their patients but kept it constant and did not compare the depth of anaesthesia between the test and control groups. BIS values were not documented in other studies. In our study, we had kept MAC constant by varying Sevoflurane and BIS values were recorded. We aimed to study the intraoperative depth between the two groups. Coming to the BIS values recorded in our study, there was significant difference at induction and 5 minutes after intubation. BIS values were higher in group A than group B. After induction, in Group the mean BIS was 42.60 whereas in Group B it was 36.43. Similarly, 5 minutes after intubation, mean BIS was 49.07 in Group A and 39.80 in Group B. In both groups the depth of anaesthesia was adequate but group B had lower BIS values than group A.
BIS values were maintained between 35 and 60 throughout the intraoperative period in both the groups. There was no increase in BIS values above 65 during the surgery in both groups denoting that there was no lightening of plane of anaesthesia. At the time of extubation, we found no significant difference in BIS values as we stop the infusions before extubation. This helps to overcome the delayed recovery of patients as was shown in other studies.12
Summing up the observations of our study, in the opioid-free group we had decrease in HR and increase in MAP. In addition, the depth of anaesthesia was adequate and comparable to the opioid-based group.
Hemodynamically, heart rates did not vary much between the two groups and the MAP values were higher in the opioid-free group closer to intubation and extubation. This rise in blood pressure due to intubation and extubation response could be eliminated by increasing the dose of Dexmedetomidine and continuing the infusion even after extubation and also in the recovery room. This will provide stable hemodynamics and reduced pain in the post-operative period.
Limitations
There are certain limitations in our study. The sample size in our study was 60. Larger sample size might yield more reliable results. We have included only ASA grade 1 and 2 and only laparoscopic surgeries lasting less than 3 hours, the results cannot be applied to high-risk patients and long duration surgeries
Conclusion
Heart rate at extubation is significantly lower in Group B than in Group A. At all other times, there is no significant difference in heart rates among the two groups. There were no extreme increases or decreases in heart rate in Group B.
Mean arterial pressure (MAP) is significantly higher in Group B than in Group A after induction, 1 minute and 5 minutes after intubation and at extubation. At all other times, there is no significant difference in Mean arterial pressure among the two groups. Inspite of higher MAP values, there were no profound increases in MAP values among patients of Group B.
Bispectral index (BIS) is significantly lower in Group B than in Group A at induction and at 5 minutes after intubation. At all other times the BIS showed no significant difference among the two groups.
This opioid-free, multimodal regimen consisting of Dexmedetomidine, Lignocaine, Ketamine and Dexamethasone provides reduction of post-operative pain scores, total analgesic consumption and elimination of the distressing side-effects of opioids. Additionally, it gives similar intra-operative hemodynamic stability and depth of anaesthesia comparable to the opioid-based approach.
Thus, it can be safely used in ASA-1 and 2 patients who do not have any contraindications for these drugs and also for patients at risk of opioid dependence.
Therefore, this opioid-free, multimodal approach can replace the single opioid-based approach of anaesthesia management and eventually become the routine approach for management of analgesia in the conduct of general anaesthesia.
Recommendations
This opioid-free, multimodal regimen consisting of Dexmedetomidine, Lignocaine, Ketamine and Dexamethasone can be safely used in ASA-1 and 2 patients undergoing laparoscopic surgeries lasting less than 3 hours. Similar studies can be done in paediatric populations, in high risk, elderly age groups and on longer duration laparoscopic surgeries.